Allen & Co. represents Wal-Mart in the latest sign that smaller upstarts are challenging the big banks on merger deals.
Wall Street — and the stock market — may now be comfortable with the idea of a Hillary Clinton victory, but her policies could be negative for many companies.
Bayer surpassed second-quarter earnings expectations and raised its guidance for the year on strong gains in stroke prevention pill Xarelto.
John Rountree, managing partner of Novasecta, discusses earnings at Bayer and the company's progress in acquiring Monsanto.
Bayer, the German drugmaker trying to acquire U.S. seed company Monsanto, surpassed second-quarter earnings expectations and raised its guidance for the year.
Jim Cramer rattles off his take on caller favorite stocks, including this smokin' digital realty play.
Donald Trump signaled that big banks could be a short bet if he wins office, but his presidency could help plenty of other companies.
European equities posted strong gains by Wednesday's close, as a rally in technology stocks and a slew of positive earnings helped boost sentiment.
U.S. stock-index futures rose on Wednesday as investors cheered better-than-expected earnings from Morgan Stanley.
CNBC's David Faber has details on Monsanto rejecting Bayer's latest bid for the company.
Monsanto said a sweetened $125-per-share offer from chemicals group Bayer is "financially inadequate and insufficient to ensure deal certainty."
Some of the names on the move ahead of the open.
Boutique banks have increased their market share of M&A over big Wall Street firms year over year.
These are the stocks on the move ahead of the opening bell.
U.S. sovereign bond yields pared gains after gunfire was heard and jets were seen flying in the Turkish capital of Ankara.
U.S. stock indexes futures traded higher Friday after better-than-expected retail sales.
Even though Bayer sweetened the pot in its attempt to win Monsanto, analysts suggest the seed company's board is likely to reject the offer.
Bayer raised its offer for Monsanto to $125 per share after addressing Monsanto's concerns over financing, the company said Thursday.
CNBC's Dominic Chu reports that Bayer has raised its offer for Monsanto to $125 per share, up from $122.
CNBC's David Faber reports on Mondelez's offer on Hershey, as well as an update on Monsanto.